Pantoprazole Aptapharma (Pantoprazole)

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

• Gastroesophageal reflux disease (GERD): reduces gastric acid exposure, relieving heartburn and promoting esophageal healing.
• Erosive esophagitis: accelerates mucosal repair and prevents further erosion.
• Peptic ulcer disease: facilitates ulcer healing and reduces recurrence risk.
• Stress ulcer prophylaxis: prevents stress‑related gastric mucosal injury in critically ill patients.

• Pantoprazole selectively and irreversibly inhibits the H+/K+ ATPase enzyme (the gastric proton pump) located on the secretory surface of gastric parietal cells. By blocking this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, thereby increasing gastric pH and allowing damaged mucosa to heal.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: watery stools, usually transient.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: cramp-like discomfort.
• Flatulence: increased intestinal gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis.
• Anaphylaxis: life‑threatening allergic reaction.
• Stevens‑Johnson syndrome: severe skin and mucosal lesions.
• Hepatic enzyme elevation: potential liver injury.
• Neutropenia or thrombocytopenia: reduced blood cell counts.
• Severe hypomagnesemia: low magnesium levels with prolonged use.

Before initiating therapy, consider patient‑specific factors and monitor for potential complications.

• Assess renal function: dose adjustment may be required in severe renal impairment.
• Monitor for infections: increased risk of Clostridioides difficile colitis.
• Caution with drugs requiring gastric acidity: absorption of certain antifungals and antivirals may be reduced.
• Use carefully in hepatic impairment: monitor liver function tests.
• Pregnancy and lactation: safety not established; use only if benefit outweighs risk.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Pantoprazole may alter the pharmacokinetics of several concomitant medications.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
• Warfarin: enhanced anticoagulant effect, raising INR and bleeding risk.
• Ketoconazole: decreased absorption, reducing antifungal efficacy.

Moderate Interactions (Monitor Closely)

• Digoxin: possible increase in serum levels, requiring monitoring.
• Atazanavir: reduced exposure, potentially compromising antiviral therapy.